OraSure Technologies to Present at the Canaccord Genuity 34th Annual Growth
BETHLEHEM, Pa., Aug. 6, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will
speak to the investment community at the Canaccord Genuity 34^th Annual Growth
Conference in Boston, Massachusetts. The conference will be simultaneously
webcast over the Internet.
Mr. Michels is scheduled to speak August 13, 2014, at approximately 11:00 a.m.
Eastern Time (08:00 a.m. Pacific Time). Interested investors can access the
live webcast of the presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link. A replay of the
webcast will be available on OraSure Technologies' web site for seven days.
Alternatively, you can access the live webcast of the presentation via the
following link http://wsw.com/webcast/canaccord14/osur.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and
distribution of point of care diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and tests for various drugs of abuse. The Company
sells the OraQuick® In-Home HIV Test, the first and only rapid HIV test
approved by the U.S. Food and Drug Administration for sale to the consumer
over-the-counter market in the U.S. In addition, the Company is a leading
provider of oral fluid sample collection, stabilization and preparation
products for molecular diagnostic applications. OraSure's portfolio of
products is sold globally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health organizations,
research and academic institutions, distributors, government agencies,
physicians' offices, and commercial and industrial entities. The Company's
products enable healthcare providers to deliver critical information to
patients, empowering them to make decisions to improve and protect their
For more information on OraSure Technologies, please visit www.orasure.com.
CONTACT: Company contact:
Ronald H. Spair
Chief Financial Officer
Press spacebar to pause and continue. Press esc to stop.